Clinical Edge Journal Scan

Clinical Edge Journal Scan

Gastric cancer: Add-on apatinib to neoadjuvant chemotherapy shows good response

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

HER2-negative gastric cancer: Docetaxel-based chemotherapy does not improve outcomes

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

Gastric cancer: Function-preserving surgery fails to show noninferiority

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

High D-dimer levels tied to mortality and VTE risks in patients with lung cancer

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

Advanced NSCLC: Adding antiangiogenic drug to second-line therapy boosts survival outcomes

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

Advanced nonsquamous NSCLC: First-line ICI-chemo tops bevacizumab-chemo in OS

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

Unresectable stage III NSCLC: Platinum-doublet chemotherapy beneficial as second-line therapy

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

Stage I NSCLC: No real-world survival benefit with tegafur-uracil chemotherapy

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

High prevalence of frailty in patients with lung cancer

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

Early-stage NSCLC: Adjuvant pembrolizumab improves DFS

Publish date: April 25, 2022

• Read More

Clinical Edge Journal Scan

EGFR+ stage IV NSCLC: TKI treatment boosts survival

Publish date: April 25, 2022

• Read More

Pages

• « first
• …
• 35
• 36
• 37
• 38
• 39
• 40
• 41
• 42
• 43
• …
• last »